Xenotransplantation, xenogeneic infections, biotechnology, and public health

Mount Sinai Journal of Medicine

Volumn 76, Issue 5, 2009, Pages 435-441

  Chapman, Louisa E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Porcine endogenous virus; Public health; Xenogeneic infections; Xenotransplantation

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLOTRANSPLANTATION; ANIMAL HUSBANDRY; BIOENGINEERING; BIOTECHNOLOGY; EPIDEMIC; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HEPATITIS B; HEPATITIS B VIRUS; HERD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MAMMAL CELL; MICROORGANISM; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; PANCREAS ISLET TRANSPLANTATION; PANDEMIC; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH SERVICE; RETROVIRUS; RETROVIRUS INFECTION; REVIEW; STEM CELL TRANSPLANTATION; VIRUS CARRIER; WORLD HEALTH ORGANIZATION; XENOGRAFT; XENOTRANSPLANTATION; ZOONOSIS;

ANIMALS; BIOTECHNOLOGY; ENDOGENOUS RETROVIRUSES; HUMANS; PUBLIC HEALTH; PUBLIC HEALTH PRACTICE; RETROVIRIDAE INFECTIONS; RISK FACTORS; SWINE; SWINE DISEASES; TRANSPLANTATION, HETEROLOGOUS; UNITED STATES; ZOONOSES;

EID: 70350731106     PISSN: 00272507     EISSN: 19317581     Source Type: Journal    
DOI: 10.1002/msj.20131     Document Type: Review

References (31)

1. United States Public Health Service. Public health service guideline on infectious disease issues in xenotransplantation. MMWR Recomm Rep 2001; 50: 1-46.
2. Chapman LE, Bloom ET. Clinical xenotransplantation. JAMA 2001; 285: 2304-2306.
3. Boneva, R., Folks TM, Chapman LE. Infectious disease issues associated with xenotransplantation. Clin Microbiol Rev 2001; 14: 1-14. (Pubitemid 32096204)
4. United Network for Organ Sharing. Available at: http://www.unos.org. Accessed June 2009.
5. Starzl TE, Fung J, Tzakis A, et al. Baboon to human transplantation. Lancet 1993; 341: 65-71.
6. Gaines BA, Colson YL, Kaufman CL, Ildstad ST. Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients. Exp Hematol 1996; 24: 902-913.
7. Ilstad ST. Xenotransplantation for AIDS. Lancet 1996; 347: 761.
8. Chapman LE, Salomon DR, Patterson AP, et al. Xenotransplantation and xenogeneic infections. N Engl J Med 1995; 333: 1498-1501.
9. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009; 32: 287-294.
10. Minshall ME, Roze S, Palmer AJ, et al. Treating diabetes to accepted standards of care: a 10-year projection of these estimated economic and health impact in patients with type 1 and type 2 diabetes mellitus in the United States. Clin Ther 2005; 27: 940-950. (Pubitemid 41583533)
11. Chapman LE, Khabbaz RF. Review: etiology and epidemiology of the Four Corners hantavirus outbreak. Infect Agents Dis 1994; 3: 234-244.
12. Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003; 349: 1236-1245.
13. Vana G, Westover KM. Origin of the 1918 Spanish influenza virus: a comparative genomic analysis. Mol Phylogenet Evol 2008; 47: 1100-1110.
14. Hahn BH, Shaw GM, De Cock KM, et al. AIDS as a zoonosis: scientific and public health implications. Science 2000; 287: 607-614. (Pubitemid 30070900)
15. Xenotransplantation: Guidance on Infectious Disease Prevention and Management. Geneva, Switzerland: World Health Organization; 1998.; WHO document WHO/EMC/ZOO/98.1.
16. Mahy BWJ. The Dictionary of Virology. 4th ed. London, United Kingdom: Academic Press; 2009; 407.
17. Brown J, Matthews L, Sandstrom PA, Chapman LE. Xenotransplantation and the risk of retroviral zoonosis. Trends Microbiol 1998; 6: 411-415.
18. Chapman LE, Switzer WM, Sandstrom PA, et al. Infectious disease issues in xenotransplantation. In: Scheld WM, Craig WA, Hughes JM, eds. Emerging Infections 3. Washington, DC: ASM Press; 1999.
19. Bloom, ET. Xenotransplantation-Federal Regulatory Considerations. In: Salomon DR, Wilson C, eds. Current Topics in Microbiology: Xenotransplantation. Berlin: Springer-Verlag; 2003; 239-251.
20. US Food and Drug Administration. Draft guidance for industry: precautionary measures to reduce the possible risk of transmission of zoonoses by blood and blood products from xenotransplantation product recipients and their contacts. Available at: http://www.fda.gov/biologicsbloodvaccines/ guidancecomplianceregulatoryinformation/guidances/blood/ucm075125.htm. Accessed June 2009.
21. Heneine W. Strategies for diagnosis of xenotransplant-associated retroviral infections. Mol Diagn 1996; 1: 255-260. (Pubitemid 126736427)
22. Heneine W, Switzer WM. Highly sensitive and specific polymerase chain reaction assays for detection of baboon and pig cells following xenotransplantation in humans. Transplantation 1996; 62: 1360-1362. (Pubitemid 27008570)
23. Patience C, Patton GS, Takeuchi Y, et al. No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet 1998; 352: 699-701. (Pubitemid 28398706)
24. Heneine W, Tibell A, Switzer WM, et al. No evidence of infection with the porcine endogenous retrovirus in human recipients of porcine islet cell xenografts. Lancet 1998; 352: 695-699. (Pubitemid 28398705)
25. Paradis K, Langford G, Long Z, et al. Search for cross species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science 1999; 285: 1236-1241. (Pubitemid 29398604)
26. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci 1996; 93: 705-708. (Pubitemid 26041153)
27. Chapman LE. Xenotransplantation. In: Burroughs T, Knobler S, Lederberg J, eds. The Emergence of Zoonotic Diseases: Understanding the Impact on Animal and Human Health. Washington, DC: National Academy Press; 2001; 17-20.
28. Chapman LE, Wilson CA. Commentary: implications of the advent of homozygous α1,3-galactosyltransferase gene-deficient pigs on transmission of infectious agents. Xenotransplantation 2003; 10: 287-288.
29. Nyberg SL, Hibbs JJR, Hardin JA, et al. Transfer of porcine endogenous retrovirus across hollow fiber membranes: significance to a bio-artificial liver. Transplantation 1999; 67: 1251-1255.
30. Quri SH, Magre S, Garcia-Lerma JG, et al. Susceptibility of the porcine endogenous retroviruses to reverse transcriptase and protease inhibitors. J Virol 2001; 75: 1048-1053. (Pubitemid 32037308)
31. Simeonovic CJ, Ziolkowski AF, Popp SK, et al. Porcine endogenous retrovirus encodes xenoantigens involved in porcine cellular xenograft rejection by mice. Transplantation 2005; 79: 1674-1682.